Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Jonathan Drachman
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
therapies for cancer
therapies for inflammatory diseases |
| gptkbp:focusesOn |
gptkb:immunotherapy
immunometabolism |
| gptkbp:foundedYear |
2019
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://www.immetas.com/
|
| gptkbp:bfsParent |
gptkb:Life_Biosciences
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Immetas Therapeutics
|